Boundless Bio, Inc. Common Stock (BOLD) — Net Asset Quality Index
Boundless Bio, Inc. Common Stock (BOLD) has a Net Asset Quality Index of 65.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $168.72 Million minus total liabilities of $58.55 Million yields net assets of $110.17 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Boundless Bio, Inc. Common Stock's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Boundless Bio, Inc. Common Stock Net Asset Quality Index Over Time (2016–2024)
This chart shows how Boundless Bio, Inc. Common Stock's Net Asset Quality Index has evolved across 7 annual periods from 2016 to 2024. As of September 2025, the index stands at 65.3%, representing net assets of $110.17 Million against total assets of $168.72 Million USD. See BOLD working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Boundless Bio, Inc. Common Stock (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Boundless Bio, Inc. Common Stock from 2016 to 2024, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BOLD market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.0% | $150.64 Million | $206.41 Million | $55.77 Million | ▲ +170.8 pp |
| 2023 | -97.8% | $-127.08 Million | $129.89 Million | $256.98 Million | ▲ +8.5 pp |
| 2022 | -106.3% | $-81.70 Million | $76.83 Million | $158.53 Million | ▼ -72.8 pp |
| 2021 | -33.6% | $-38.19 Million | $113.72 Million | $151.91 Million | ▼ -127.3 pp |
| 2018 | 93.7% | $442.75 Million | $472.56 Million | $29.80 Million | ▲ +6.0 pp |
| 2017 | 87.7% | $156.60 Million | $178.66 Million | $22.06 Million | ▲ +3.6 pp |
| 2016 | 84.0% | $119.37 Million | $142.06 Million | $22.69 Million | — |